PTAB extends an IPR for good cause for the first time
The PTAB has extended the one-year deadline in Minerva Surgical v Hologic by six months. The final written decision in the inter partes review was originally set to expire two days after the Federal Circuit released its en banc Aqua Products opinion
The Patent Trial and Appeal Board (PTAB) has extended the
deadline for issuing a final written decision in Minerva
Surgical v Hologic by six months. This is the first time the
Board has ever extended the deadline in an inter...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.